首页> 外国专利> Composition For Red Ginseng Extract Mediated Retinal Regeneration in Normal Ageing And Macular Degeneration

Composition For Red Ginseng Extract Mediated Retinal Regeneration in Normal Ageing And Macular Degeneration

机译:红参提取物在正常衰老和黄斑变性中介导的视网膜再生的成分

摘要

The present invention relates to a composition comprising a red ginseng extract as an active ingredient for delaying, preventing, and treating age-related macular degeneration and, more specifically, to a composition comprising a red ginseng extract, which normalizes the function of the Bruchs membrane of an eye, as an active ingredient for delaying, preventing, and treating age-related macular degeneration. The composition of the present invention removes substances deposited on the Bruchs membrane and improves the transport function of the Bruchs membrane so that the Bruchs membrane may be regenerated through cell reactions in retinal pigment epithelium (RPE). The treatment of the present invention can prevent and treat functional eye failure as a result of degeneration with age. [Reference numerals] (AA) Fluid transport; (BB) Age(years); (CC) Function stop; (DD) Macular degeneration; (EE) Ginseng treatment
机译:本发明涉及一种包含红参提取物作为用于延迟,预防和治疗与年龄有关的黄斑变性的活性成分的组合物,并且更具体地,涉及一种包含红参提取物的组合物,其使Bruchs膜的功能正常化。作为延缓,预防和治疗与年龄有关的黄斑变性的有效成分。本发明的组合物除去沉积在布鲁赫斯膜上的物质并改善布鲁赫斯膜的转运功能,使得布鲁赫斯膜可以通过视网膜色素上皮(RPE)中的细胞反应而再生。本发明的治疗可以预防和治疗由于年龄的变性而导致的功能性眼衰竭。 [附图标记](AA)流体传输; (BB)年龄(岁); (CC)功能停止; (DD)黄斑变性; (EE)人参治疗

著录项

  • 公开/公告号KR101449469B1

    专利类型

  • 公开/公告日2014-10-14

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20130050575

  • 申请日2013-05-06

  • 分类号A61K36/258;A61P27/02;A61P27;

  • 国家 KR

  • 入库时间 2022-08-21 15:39:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号